新华制药股价下跌1.17% 新药入场能否破解业绩困局

金融界2025-07-23

截至2025年7月22日收盘，新华制药股价报16.89元，较前一交易日下跌1.17%，成交额3.38亿元。新华制药主营业务涵盖化学原料药、制剂及医药中间体，产品包括布洛芬、阿司匹林等原料药及介宁、舒泰得等制剂。公司隶属于化学制药板块，是华鲁控股集团核心子公司。近日，新华制药宣布获得马来酸阿伐曲泊帕片的上市许可持有人资格，正式进入止血药市场。该药品适用于慢性肝病相关血小板减少症及免疫性血小板减少症...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2553263836?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-23 03:09","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2553263836","market":"hk","top_or_hot":-1,"title":"新华制药股价下跌1.17% 新药入场能否破解业绩困局","media":"金融界","content":"<div>\n<p>截至2025年7月22日收盘，新华制药股价报16.89元，较前一交易日下跌1.17%，成交额3.38亿元。新华制药主营业务涵盖化学原料药、制剂及医药中间体，产品包括布洛芬、阿司匹林等原料药及介宁、舒泰得等制剂。公司隶属于化学制药板块，是华鲁控股集团核心子公司。近日，新华制药宣布获得马来酸阿伐曲泊帕片的上市许可持有人资格，正式进入止血药市场。该药品适用于慢性肝病相关血小板减少症及免疫性血小板减少症...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723031730954d6157&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>新华制药股价下跌1.17% 新药入场能否破解业绩困局</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n新华制药股价下跌1.17% 新药入场能否破解业绩困局\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-23 03:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723031730954d6157&s=b><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>截至2025年7月22日收盘，新华制药股价报16.89元，较前一交易日下跌1.17%，成交额3.38亿元。新华制药主营业务涵盖化学原料药、制剂及医药中间体，产品包括布洛芬、阿司匹林等原料药及介宁、舒泰得等制剂。公司隶属于化学制药板块，是华鲁控股集团核心子公司。近日，新华制药宣布获得马来酸阿伐曲泊帕片的上市许可持有人资格，正式进入止血药市场。该药品适用于慢性肝病相关血小板减少症及免疫性血小板减少症...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723031730954d6157&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1515","symbol_name":"抗疫概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723031730954d6157&s=b","article_id":"2553263836","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723031730954d6157&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2553263836","pubTimestamp":1753211380,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"截至2025年7月22日收盘，新华制药股价报16.89元，较前一交易日下跌1.17%，成交额3.38亿元。新华制药主营业务涵盖化学原料药、制剂及医药中间体，产品包括布洛芬、阿司匹林等原料药及介宁、舒泰得等制剂。近日，新华制药宣布获得马来酸阿伐曲泊帕片的上市许可持有人资格，正式进入止血药市场。该药品适用于慢性肝病相关血小板减少症及免疫性血小板减少症患者，市场规模约10.5亿元。7月22日，新华制药主力资金净流出3645.74万元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1515":"抗疫概念","BK1191":"制药","00719":"山东新华制药股份"},"translate_title":"Xinhua Pharmaceutical's stock price fell 1.17%. Can the entry of new drugs solve the performance dilemma?","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00719":0.9},"content_text":"截至2025年7月22日收盘，新华制药股价报16.89元，较前一交易日下跌1.17%，成交额3.38亿元。新华制药主营业务涵盖化学原料药、制剂及医药中间体，产品包括布洛芬、阿司匹林等原料药及介宁、舒泰得等制剂。公司隶属于化学制药板块，是华鲁控股集团核心子公司。近日，新华制药宣布获得马来酸阿伐曲泊帕片的上市许可持有人资格，正式进入止血药市场。该药品适用于慢性肝病相关血小板减少症及免疫性血小板减少症患者，市场规模约10.5亿元。不过，公司2024年净利润同比下降5.33%，2025年一季度营收及净利润继续下滑，面临“增收不增利”的挑战。7月22日，新华制药主力资金净流出3645.74万元。风险提示：股市有风险，投资需谨慎。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2553263836","isCrawlerRequest":true}